Melatonin 5 mg
Natural health product licensed in Canada
- Other names
- AthlTX Melatonin-5, Elle Factor Melatonin-5, Future Nutrition Melatonin-5, Humabolic Melatonin-5, MVP Melatonin-5, Melatonin-5, PHP Melatonin-5
- Licence holder
- Konsar Future Nutrition Inc.
- NPN or DIN-HM
- 80051982
- Status
- Inactive licence
- Licence date
- 19 June 2014
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Sucralose, Cellulose microcristalline, Hypromellose, Betterave rouge, Saveur de punch aux fruits, Lactose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps re-set the body's sleep-wake cycle. Helps to reduce the time it takes to fall asleep in people with delayed sleep phase disorder. Helps increase the total sleep time in people suffering from sleep restriction or altered sleep schedule. Helps to prevent or reduce the effects of jet lag (daytime fatigue, sleep disturbance) for people travelling by plane easterly across two or more time zones.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Mild gastrointestinal symptoms (nausea, vomiting, or cramping) have been known to occur in which case, discontinue use. Rare allergic reactions have been known to occur in which case, discontinue use.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product.
- Précautions et mises en garde
Consumption with alcohol, other medications or natural health products with sedative properties is not recommended. If you are taking one of the following medications, consult a health care practitioner prior to use: anticoagulant, anticonvulsant, blood pressure medications, immunosuppressive medications, sedative, hypnotic or psychotropic medications, or steroids. If you have one of the following conditions, consult a health care practitioner prior to use: asthma, cardiovascular disease, chronic kidney disease, depression, diabetes or hypoglycaemia, hormonal disorder, immune system disease, liver disease, migraine, or seizure disorders. If symptoms persist continuously for more than 4 weeks (chronic insomnia), consult your health care practitioner.
Source
Official Health Canada record, licence 80051982
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.